UnipharLSE:UPR +4.33%84 OCF Margin % is 5.74% as of Dec. 2025, which is 85% above its 10-year median of 3.11. GuruFocus rates LSE:UPR with a GF Score™ of 84/100 and a GF Value™ of £3.03 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 118 Medical Distribution companies, Uniphar ranks better than 61.86% on this metric.
The historical rank and industry rank for Uniphar's OCF Margin % or its related term are showing as below:
LSE:UPR'
s OCF Margin % Range Over the Past 10 Years
Min: -0.62 Med: 3.11 Max: 6.43
Current: 3.56
During the past 10 years, the highest OCF Margin % of Uniphar was 6.43%. The lowest was -0.62%. And the median was 3.11%.
LSE:UPR's OCF Margin % is ranked better than 61.86% of 118
companies
in the Medical Distribution industry
Industry Median: 2.24
vs LSE:UPR: 3.56
Uniphar OCF Margin % Related Terms
Uniphar OCF Margin % Historical Data
* Premium members only.
The historical data trend for Uniphar's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Uniphar's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uniphar OCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Uniphar's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Uniphar's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uniphar (LSE:UPR) has a OCF Margin % of 5.74% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Uniphar and its competitors. This is 85% above median its historical median of 3.11. According to the industry distribution chart, Uniphar ranks #45 out of 118 companies in the Medical Distribution industry, placing it in the top 38.1%.
Is Uniphar's OCF Margin % too high?
Uniphar's current OCF Margin % of 5.74% is 85% above median its 10-year median of 3.11. The Medical Distribution industry median OCF Margin % is 2.24. Uniphar's value of 5.74% is 156.3% above this industry median. Based on the distribution chart, Uniphar ranks #45 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Uniphar has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's OCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Uniphar ranks #45 out of 118 companies for OCF Margin %. This puts Uniphar in the upper half of its industry. The industry median OCF Margin % is 2.24. Uniphar's value of 5.74% is 156.3% above this benchmark. While the company's 10-year median is 3.11 vs. the industry median of 2.24, Uniphar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Distribution company?
The median OCF Margin % among Medical Distribution companies is 2.24, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uniphar's current OCF Margin % of 5.74% is 156.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Uniphar and its competitors. For the Medical Distribution industry, the median OCF Margin % is 2.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uniphar's current OCF Margin % is 5.74%, which is 85% above median its own 10-year median of 3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (LSE:UPR) is currently considered Significantly Overvalued. The stock's GF Value™ is £3.03, compared to a current price of £4.10 — trading 35.3% above its estimated fair value. The current OCF Margin % is 5.74%, which is 85% above median its 10-year median of 3.11 and 156.3% above the Medical Distribution industry median of 2.24. Uniphar's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Uniphar (LSE:UPR), the current OCF Margin % is 5.74% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uniphar (LSE:UPR) Overvalued in 2026?
Based on GuruFocus' analysis, Uniphar stock appears to be overvalued.
The current stock price of £4.10 is trading 35.3% above its estimated GF Value™ of £3.03.
GuruFocus considers Uniphar to be Significantly Overvalued.
Key valuation signals for LSE:UPR:
OCF Margin %: 5.74% (85% above median its 10-year median of 3.11)
GF Value™: £3.03 vs. price of £4.10 (35.3% above fair value)
Industry Position: 156.3% above the Medical Distribution median (#45 of 118)
No single metric tells the full story. See the LSE:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
84GF Score
Get the complete analysis for LSE:UPR
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:UPR has been successfully added to your 
